Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 1,140Congress 29Executive branch 6Insiders 1,105
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

buys only · $1M+ · 1,140 trades

Trades
1,140
Buys 1,140 · Sells 0
People
336
Stocks
204
Disclosed value
$10.4B
range midpoints · Congress & executive
Filed late
160
  1. ▲ BUYMichael E Maroone DirectorCVNA Carvana Co.$1.3Mdisclosed Aug 4 · filed 4 days after the trade
  2. ▲ BUYCatalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.$1.5Mdisclosed Jul 30 · filed 2 days after the trade
  3. ▲ BUYJack Jiajia Huang Chief Executive OfficerCOE 51Talk Online Education Group$7.7Mdisclosed Jul 30 · filed 3 days after the trade
  4. ▲ BUYCatalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.$13Mdisclosed Jul 30 · filed the same day
  5. ▲ BUYJack Jiajia Huang Chief Executive OfficerCOE 51Talk Online Education Group$3Mdisclosed Jul 30 · filed 6 days after the trade · late
  6. ▲ BUYAH Bio Fund II, L.P. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  7. ▲ BUYBenjamin A Horowitz 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  8. ▲ BUYAH Bio Fund III, L.P. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  9. ▲ BUYAH Equity Partners Bio II, L.L.C. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  10. ▲ BUYOrbiMed Capital GP VIII LLC DirectorSCTX Scribe Therapeutics, Inc.$15Mdisclosed Jul 29 · filed 2 days after the trade
  11. ▲ BUYOrbimed Advisors LLC DirectorSCTX Scribe Therapeutics, Inc.$15Mdisclosed Jul 29 · filed 2 days after the trade
  12. ▲ BUYAH Equity Partners Bio III, L.L.C. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  13. ▲ BUYCarl L Gordon DirectorSCTX Scribe Therapeutics, Inc.$15Mdisclosed Jul 29 · filed 2 days after the trade
  14. ▲ BUYMarc L Andreessen 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  15. ▲ BUYDurable Capital Partners LP 10% ownerGSHD Goosehead Insurance, Inc.$1.3Mdisclosed Jul 28 · filed 4 days after the trade
  16. ▲ BUYAvoro Capital Advisors LLC DirectorSCTX Scribe Therapeutics, Inc.$1.1Mdisclosed Jul 28 · filed 4 days after the trade
  17. ▲ BUYDurable Capital Partners LP 10% ownerGSHD Goosehead Insurance, Inc.$1.8Mdisclosed Jul 28 · filed 4 days after the trade
  18. ▲ BUYAvoro Ventures LLC DirectorSCTX Scribe Therapeutics, Inc.$1.1Mdisclosed Jul 28 · filed 4 days after the trade
  19. ▲ BUYBehzad Aghazadeh DirectorSCTX Scribe Therapeutics, Inc.$35Mdisclosed Jul 28 · filed 4 days after the trade
  20. ▲ BUYAvoro Capital Advisors LLC DirectorSCTX Scribe Therapeutics, Inc.$35Mdisclosed Jul 28 · filed 4 days after the trade
  21. ▲ BUYDurable Capital Partners LP 10% ownerGSHD Goosehead Insurance, Inc.$1.5Mdisclosed Jul 28 · filed 4 days after the trade
  22. ▲ BUYThomas M Moriarty EVP, M&A and Corporate AffairsACI Albertsons Companies, Inc.$2Mdisclosed Jul 28 · filed 1 day after the trade
  23. ▲ BUYBehzad Aghazadeh DirectorSCTX Scribe Therapeutics, Inc.$1.1Mdisclosed Jul 28 · filed 4 days after the trade
  24. ▲ BUYDurable Capital Partners LP 10% ownerGSHD Goosehead Insurance, Inc.$2.1Mdisclosed Jul 28 · filed 4 days after the trade
  25. ▲ BUYAvoro Ventures LLC DirectorSCTX Scribe Therapeutics, Inc.$35Mdisclosed Jul 28 · filed 4 days after the trade